Biotechnology company Fiji Kava raises A$5.2M in ASX IPO
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Fiji Kava Ltd., a company developing therapeutics using the kava plant, raised A$5.2 million in its IPO on the Australia Securities Exchange.
The Subiaco, Australia-based company sold 26 million ordinary shares at 20 Australian cents per share in the offering.
Pac Partners Securities Pty Ltd. acted as lead manager for the offering.